Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.43 USD | +4.42% | -0.46% | -6.54% |
20/03 | UBS Adjusts Singular Genomics Systems Price Target to $0.50 From $0.40, Maintains Neutral Rating | MT |
18/03 | Transcript : Singular Genomics Systems, Inc., Q4 2023 Earnings Call, Mar 18, 2024 |